Industries > Pharma > Next-Generation Sequencing Market Report 2019-2029

Next-Generation Sequencing Market Report 2019-2029

Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Instruments, Reagents & Consumables, Services, Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others

PAGES: 189
PRODUCT CODE: PHA0379

DOWNLOAD FREE SAMPLE
Clear
WOOCS 2.2.1
SKU: PHA0379 Categories: , Tag:

The next generation sequencing market is estimated to have reached $7bn in 2018. Both genetic screening and diagnostic segments dominated the next generation sequencing market in 2018.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Application:
• Drug Discovery
• Genetic Screening
• Diagnostics
• Personalized Medicine
• Agriculture and Animal Research
• Infectious Diseases
• Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Technology:
• Whole-Genome Sewuencing
• Targeted Re-Sequencing
• Exome Sequencing
• RNA Seq
• Chip Seq
• De Novo Sequencing
• Methyl Seq
• Others

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Product:
• Instruments
• Reagents & Consumables
• Services

Revenue forecast to 2029 of the Global Next Generation Sequencing Market by End User:
• Hospital & Healthcare Institution
• Academics
• Biotechnology
• Pharmaceutical
• Others

• Revenue forecast to 2029 of the Global Next Generation Sequencing Market by Regional and National Market:

• North America
• US
• Canada

• Latin America
• Brazil
• Mexico
• Rest of Latin America

• Europe
• Germany
• The UK
• Italy
• France
• Spain
• Russia
• Rest of Europe

• Asia-Pacific
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• South Korea
• Rest of Asia-Pacific

• MEA
• GCC Countries
• Israel
• Rest of Middle East

• Africa
• South Africa
• Central Africa
• North Africa

Each regional market is further segmented by submarkets.

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies’ operations:
Agilent Technologies, Inc.
BGI (Beijing Genomics Institute)
Eurofins Scientific
F. Hoffmann-La Roche AG
Illumina, Inc
Macrogen, Inc
Oxford Nanopore Technologies, Ltd
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc

Buy our report today Next-Generation Sequencing Market Forecast 2019-2029: Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Instruments, Reagents & Consumables, Services, Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Next-Generation Sequencing Market Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Next-Generation Sequencing Market Report 2019-2029


Latest Pharma news

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Visiongain Publishes Vaccine Sales Market Report 2022-2032

Rising epidemic potential, a growing emphasis on therapeutic vaccines, and new markets are projected to provide considerable growth prospects for vaccine providers.

30 March 2022

READ

Categories